世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 性感染症（STDs）検査機器の世界市場成長2025-2031年Global Sexually Transmitted Diseases (STDs) Testing Devices Market Growth 2025-2031 世界の性感染症（STDs）検査機器市場規模は、2025年の100万米ドルから2031年には100万米ドルに成長すると予測されており、2025年から2031年までの年平均成長率は％と予測されている。 性感染症（STDs）検査機器... もっと見る
サマリー世界の性感染症（STDs）検査機器市場規模は、2025年の100万米ドルから2031年には100万米ドルに成長すると予測されており、2025年から2031年までの年平均成長率は％と予測されている。性感染症（STDs）検査機器の米国市場は、2024年の100万米ドルから2031年には100万米ドルに増加すると予測され、2025年から2031年までの年平均成長率は%である。 性感染症（STDs）検査機器の中国市場は、2024年の100万米ドルから2031年には100万米ドルに、2025年から2031年までの年平均成長率は％と推定される。 性感染症（STDs）検査機器のヨーロッパ市場は、2024年の100万米ドルから2031年には100万米ドルに増加し、2025年から2031年までの年平均成長率は％と推定される。 性感染症（STDs）検査機器の世界的な主要企業は、Roche Diagnostics、BioMerieux、Hologic, Inc.、Becton Dickinson & Company、Cepheid, Inc.などである。収益面では、2024年には世界の大手2社がほぼ％のシェアを占める。 LPインフォメーション社の最新調査レポート「性感染症（STDs）検査機器産業の予測」は、2024年の世界の性感染症（STDs）検査機器の総売上高を過去の売上高と比較し、2025年から2031年までの性感染症（STDs）検査機器の予測売上高を地域別・市場分野別に包括的に分析している。性感染症（STDs）検査機器の売上高を地域別、市場分野別、サブセクター別に分類し、世界の性感染症（STDs）検査機器産業の詳細な分析を百万米ドル単位で提供しています。 本インサイトレポートでは、世界の性感染症（STDs）検査機器業界を包括的に分析し、製品セグメンテーション、企業形成、収益、市場シェア、最新動向、M&A活動などに関する主要動向を明らかにします。また、本レポートでは、性感染症（STDs）検査機器のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、世界の主要企業の戦略を分析し、加速する世界の性感染症（STDs）検査機器市場におけるこれらの企業の独自の地位をより深く理解しています。 本インサイトレポートでは、性感染症（STDs）検査機器の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの質的・量的市場インプットに基づいた透明性の高い方法論により、この調査予測は世界の性感染症（STDs）検査機器の現状と将来の軌道について非常にニュアンスのある見解を提供します。 当レポートでは、性感染症（STDs）検査機器市場の製品タイプ別、用途別、主要メーカー別、主要地域別および国別の包括的な概要、市場シェア、成長機会をお届けします。 タイプ別セグメント サーマルサイクラー ラテラルフローリーダー フローサイトメーター 示差光散乱装置 その他 用途別セグメント ラボ検査 ポイントオブケア検査 本レポートはまた、市場を地域別に分けています： 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ロシュ・ダイアグノスティックス バイオメリュー ホロジック ベクトン・ディッキンソン セファイド ダナハーコーポレーション アフィメトリクス社 アレール社 アボットラボラトリーズ ディアソリン 本レポートで扱う主な質問 世界の性感染症（STDs）検査機器市場の10年間の見通しは？ 世界および地域別に、性感染症（STDs）検査機器市場の成長を促進する要因は何か？ 市場別・地域別で最も急成長するのはどの技術か？ 性感染症（STDs）検査機器市場の機会は最終市場規模によってどのように異なるのか？ 性感染症（STDs）検査機器のタイプ別、用途別の内訳は？ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for Sexually Transmitted Diseases (STDs) Testing Devices by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for Sexually Transmitted Diseases (STDs) Testing Devices by Country/Region, 2020, 2024 & 2031 2.2 Sexually Transmitted Diseases (STDs) Testing Devices Segment by Type 2.2.1 Thermal Cyclers 2.2.2 Lateral Flow Readers 2.2.3 Flow Cytometers 2.2.4 Differential Light Scattering Machines 2.2.5 Others 2.3 Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type 2.3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Market Share by Type (2020-2025) 2.3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue and Market Share by Type (2020-2025) 2.3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Price by Type (2020-2025) 2.4 Sexually Transmitted Diseases (STDs) Testing Devices Segment by Application 2.4.1 Laboratory Testing 2.4.2 Point of Care Testing 2.5 Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application 2.5.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Market Share by Application (2020-2025) 2.5.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue and Market Share by Application (2020-2025) 2.5.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Breakdown Data by Company 3.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales by Company (2020-2025) 3.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Market Share by Company (2020-2025) 3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue by Company (2020-2025) 3.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Company (2020-2025) 3.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue Market Share by Company (2020-2025) 3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Price by Company 3.4 Key Manufacturers Sexually Transmitted Diseases (STDs) Testing Devices Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Sexually Transmitted Diseases (STDs) Testing Devices Product Location Distribution 3.4.2 Players Sexually Transmitted Diseases (STDs) Testing Devices Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Sexually Transmitted Diseases (STDs) Testing Devices by Geographic Region 4.1 World Historic Sexually Transmitted Diseases (STDs) Testing Devices Market Size by Geographic Region (2020-2025) 4.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales by Geographic Region (2020-2025) 4.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic Sexually Transmitted Diseases (STDs) Testing Devices Market Size by Country/Region (2020-2025) 4.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales by Country/Region (2020-2025) 4.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue by Country/Region (2020-2025) 4.3 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth 4.4 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth 4.5 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth 4.6 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth 5 Americas 5.1 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country 5.1.1 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2025) 5.1.2 Americas Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2025) 5.2 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025) 5.3 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region 6.1.1 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region (2020-2025) 6.1.2 APAC Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Region (2020-2025) 6.2 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025) 6.3 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Sexually Transmitted Diseases (STDs) Testing Devices by Country 7.1.1 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2025) 7.1.2 Europe Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2025) 7.2 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025) 7.3 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices by Country 8.1.1 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2025) 8.1.2 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2025) 8.2 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025) 8.3 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Sexually Transmitted Diseases (STDs) Testing Devices 10.3 Manufacturing Process Analysis of Sexually Transmitted Diseases (STDs) Testing Devices 10.4 Industry Chain Structure of Sexually Transmitted Diseases (STDs) Testing Devices 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Sexually Transmitted Diseases (STDs) Testing Devices Distributors 11.3 Sexually Transmitted Diseases (STDs) Testing Devices Customer 12 World Forecast Review for Sexually Transmitted Diseases (STDs) Testing Devices by Geographic Region 12.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Market Size Forecast by Region 12.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Forecast by Region (2026-2031) 12.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global Sexually Transmitted Diseases (STDs) Testing Devices Forecast by Type (2026-2031) 12.7 Global Sexually Transmitted Diseases (STDs) Testing Devices Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 Roche Diagnostics 13.1.1 Roche Diagnostics Company Information 13.1.2 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.1.3 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 Roche Diagnostics Main Business Overview 13.1.5 Roche Diagnostics Latest Developments 13.2 BioMerieux 13.2.1 BioMerieux Company Information 13.2.2 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.2.3 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 BioMerieux Main Business Overview 13.2.5 BioMerieux Latest Developments 13.3 Hologic, Inc. 13.3.1 Hologic, Inc. Company Information 13.3.2 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.3.3 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 Hologic, Inc. Main Business Overview 13.3.5 Hologic, Inc. Latest Developments 13.4 Becton Dickinson & Company 13.4.1 Becton Dickinson & Company Company Information 13.4.2 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.4.3 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 Becton Dickinson & Company Main Business Overview 13.4.5 Becton Dickinson & Company Latest Developments 13.5 Cepheid, Inc. 13.5.1 Cepheid, Inc. Company Information 13.5.2 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.5.3 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 Cepheid, Inc. Main Business Overview 13.5.5 Cepheid, Inc. Latest Developments 13.6 Danaher Corporation 13.6.1 Danaher Corporation Company Information 13.6.2 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.6.3 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.6.4 Danaher Corporation Main Business Overview 13.6.5 Danaher Corporation Latest Developments 13.7 Affymetrix, Inc. 13.7.1 Affymetrix, Inc. Company Information 13.7.2 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.7.3 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.7.4 Affymetrix, Inc. Main Business Overview 13.7.5 Affymetrix, Inc. Latest Developments 13.8 Alere, Inc. 13.8.1 Alere, Inc. Company Information 13.8.2 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.8.3 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.8.4 Alere, Inc. Main Business Overview 13.8.5 Alere, Inc. Latest Developments 13.9 Abbott Laboratories 13.9.1 Abbott Laboratories Company Information 13.9.2 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.9.3 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.9.4 Abbott Laboratories Main Business Overview 13.9.5 Abbott Laboratories Latest Developments 13.10 DiaSorin 13.10.1 DiaSorin Company Information 13.10.2 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.10.3 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.10.4 DiaSorin Main Business Overview 13.10.5 DiaSorin Latest Developments 14 Research Findings and Conclusion
SummaryThe global Sexually Transmitted Diseases (STDs) Testing Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for Sexually Transmitted Diseases (STDs) Testing Devices by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for Sexually Transmitted Diseases (STDs) Testing Devices by Country/Region, 2020, 2024 & 2031 2.2 Sexually Transmitted Diseases (STDs) Testing Devices Segment by Type 2.2.1 Thermal Cyclers 2.2.2 Lateral Flow Readers 2.2.3 Flow Cytometers 2.2.4 Differential Light Scattering Machines 2.2.5 Others 2.3 Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type 2.3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Market Share by Type (2020-2025) 2.3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue and Market Share by Type (2020-2025) 2.3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Price by Type (2020-2025) 2.4 Sexually Transmitted Diseases (STDs) Testing Devices Segment by Application 2.4.1 Laboratory Testing 2.4.2 Point of Care Testing 2.5 Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application 2.5.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Market Share by Application (2020-2025) 2.5.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue and Market Share by Application (2020-2025) 2.5.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Breakdown Data by Company 3.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales by Company (2020-2025) 3.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Sales Market Share by Company (2020-2025) 3.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue by Company (2020-2025) 3.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Company (2020-2025) 3.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Revenue Market Share by Company (2020-2025) 3.3 Global Sexually Transmitted Diseases (STDs) Testing Devices Sale Price by Company 3.4 Key Manufacturers Sexually Transmitted Diseases (STDs) Testing Devices Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Sexually Transmitted Diseases (STDs) Testing Devices Product Location Distribution 3.4.2 Players Sexually Transmitted Diseases (STDs) Testing Devices Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Sexually Transmitted Diseases (STDs) Testing Devices by Geographic Region 4.1 World Historic Sexually Transmitted Diseases (STDs) Testing Devices Market Size by Geographic Region (2020-2025) 4.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales by Geographic Region (2020-2025) 4.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic Sexually Transmitted Diseases (STDs) Testing Devices Market Size by Country/Region (2020-2025) 4.2.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Sales by Country/Region (2020-2025) 4.2.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue by Country/Region (2020-2025) 4.3 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth 4.4 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth 4.5 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth 4.6 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales Growth 5 Americas 5.1 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country 5.1.1 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2025) 5.1.2 Americas Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2025) 5.2 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025) 5.3 Americas Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region 6.1.1 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Region (2020-2025) 6.1.2 APAC Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Region (2020-2025) 6.2 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025) 6.3 APAC Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Sexually Transmitted Diseases (STDs) Testing Devices by Country 7.1.1 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2025) 7.1.2 Europe Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2025) 7.2 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025) 7.3 Europe Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices by Country 8.1.1 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Country (2020-2025) 8.1.2 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Revenue by Country (2020-2025) 8.2 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Type (2020-2025) 8.3 Middle East & Africa Sexually Transmitted Diseases (STDs) Testing Devices Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Sexually Transmitted Diseases (STDs) Testing Devices 10.3 Manufacturing Process Analysis of Sexually Transmitted Diseases (STDs) Testing Devices 10.4 Industry Chain Structure of Sexually Transmitted Diseases (STDs) Testing Devices 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Sexually Transmitted Diseases (STDs) Testing Devices Distributors 11.3 Sexually Transmitted Diseases (STDs) Testing Devices Customer 12 World Forecast Review for Sexually Transmitted Diseases (STDs) Testing Devices by Geographic Region 12.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Market Size Forecast by Region 12.1.1 Global Sexually Transmitted Diseases (STDs) Testing Devices Forecast by Region (2026-2031) 12.1.2 Global Sexually Transmitted Diseases (STDs) Testing Devices Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global Sexually Transmitted Diseases (STDs) Testing Devices Forecast by Type (2026-2031) 12.7 Global Sexually Transmitted Diseases (STDs) Testing Devices Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 Roche Diagnostics 13.1.1 Roche Diagnostics Company Information 13.1.2 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.1.3 Roche Diagnostics Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 Roche Diagnostics Main Business Overview 13.1.5 Roche Diagnostics Latest Developments 13.2 BioMerieux 13.2.1 BioMerieux Company Information 13.2.2 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.2.3 BioMerieux Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 BioMerieux Main Business Overview 13.2.5 BioMerieux Latest Developments 13.3 Hologic, Inc. 13.3.1 Hologic, Inc. Company Information 13.3.2 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.3.3 Hologic, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 Hologic, Inc. Main Business Overview 13.3.5 Hologic, Inc. Latest Developments 13.4 Becton Dickinson & Company 13.4.1 Becton Dickinson & Company Company Information 13.4.2 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.4.3 Becton Dickinson & Company Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 Becton Dickinson & Company Main Business Overview 13.4.5 Becton Dickinson & Company Latest Developments 13.5 Cepheid, Inc. 13.5.1 Cepheid, Inc. Company Information 13.5.2 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.5.3 Cepheid, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 Cepheid, Inc. Main Business Overview 13.5.5 Cepheid, Inc. Latest Developments 13.6 Danaher Corporation 13.6.1 Danaher Corporation Company Information 13.6.2 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.6.3 Danaher Corporation Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.6.4 Danaher Corporation Main Business Overview 13.6.5 Danaher Corporation Latest Developments 13.7 Affymetrix, Inc. 13.7.1 Affymetrix, Inc. Company Information 13.7.2 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.7.3 Affymetrix, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.7.4 Affymetrix, Inc. Main Business Overview 13.7.5 Affymetrix, Inc. Latest Developments 13.8 Alere, Inc. 13.8.1 Alere, Inc. Company Information 13.8.2 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.8.3 Alere, Inc. Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.8.4 Alere, Inc. Main Business Overview 13.8.5 Alere, Inc. Latest Developments 13.9 Abbott Laboratories 13.9.1 Abbott Laboratories Company Information 13.9.2 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.9.3 Abbott Laboratories Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.9.4 Abbott Laboratories Main Business Overview 13.9.5 Abbott Laboratories Latest Developments 13.10 DiaSorin 13.10.1 DiaSorin Company Information 13.10.2 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Product Portfolios and Specifications 13.10.3 DiaSorin Sexually Transmitted Diseases (STDs) Testing Devices Sales, Revenue, Price and Gross Margin (2020-2025) 13.10.4 DiaSorin Main Business Overview 13.10.5 DiaSorin Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
LP Information社の医療分野での最新刊レポート
本レポートと同じKEY WORD（devices）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
